Reporting of Informed Consent, Standard of Care and Post-Trial Obligations in Global Randomized Intervention Trials: A Systematic Survey of Registered Trials
Cohen, Emma R.M.
O'Neill, Jennifer M.
Upshur, Ross E.G.
Developing World Bioethics 2009 August; 9(2): 74-80
OBJECTIVE: Ethical guidelines are designed to ensure benefits, protection and respect of participants in clinical research. Clinical trials must now be registered on open-access databases and provide details on ethical considerations. This systematic survey aimed to determine the extent to which recently registered clinical trials report the use of standard of care and post-trial obligations in trial registries, and whether trial characteristics vary according to setting. METHODS: We selected global randomized trials registered on http://www.clinicaltrials.gov and http://www.controlled-trials.com. We searched for intervention trials of HIV/AIDS, malaria, and tuberculosis from 9 October 2004, the date of the most recent version of the Helsinki Declaration, to 10 April 2007. RESULTS: We collected data from 312 trials. Fifty-eight percent (58%, 95% CI = 53 to 64) of trial protocols report informed consent. Fifty-eight percent (58%, 95% CI = 53 to 64) of trials report active controls. Almost no trials (1%, 95% CI = 0.5 to 3) mention post-trial provisions. Most trials measure surrogate outcomes. Twenty percent (20%, 95% CI = 16 to 25) of trials measure patient-important outcomes, such as death; and the odds that these outcomes are in a low income country are five times greater than for a developed country (odds ratio (OR) 5.03, 95% CI = 2.70 to 9.35, p =
Permanent LinkFind in a Library
Full Text from Publisher
Aids; Clinical Trials; Clinical Research; Consent; Databases; Death; Guidelines; Informed Consent; Methods; Registries; Research; Reporting; Survey; Tuberculosis; Human Experimentation Policy Guidelines / Institutional Review Boards; Informed Consent or Human Experimentation; International and Political Dimensions of Biology and Medicine;
Showing items related by title, author, creator and subject.
Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects: Systematic Review and Meta-Regression Analysis Bassler, Dirk; Briel, Matthias; Montori, Victor M; Lane, Melanie; Glasziou, Paul; Zhou, Qi; Heels-Ansdell, Diane; Walter, Stephen D.; Guyatt, Gordon H.; Flynn, David N.; Elamin, Mohamed B.; Murad, Mohammad Hassan; Abu Elnour, Nisrin O.; Lampropulos, Julianna F.; Sood, Amit; Mullan, Rebecca J.; Erwin, Patricia J.; Bankhead, Clare R.; Perera, Rafael; Ruiz Culebro, Carolina; You, John J.; Mulla, Sohail M.; Kaur, Jagdeep; Nerenberg, Kara A.; Schünemann, Holger; Cook, Deborah J.; Lutz, Kristina; Ribic, Christine M.; Vale, Noah; Malaga, German; Akl, Elie A.; Ferreira-Gonzalez, Ignacio; Alonso-Coello, Pablo; Urrutia, Gerard; Kunz, Regina; Bucher, Heiner C.; Nordmann, Alain J.; Raatz, Heike; da Silva, Suzana Alves; Tuche, Fabio; Strahm, Brigitte; Djulbegovic, Benjamin; Adhikari, Neill K.J.; Mills, Edward J.; Gwadry-Sridhar, Femida; Kirpalani, Haresh; Soares, Heloisa P.; Karanicolas, Paul J.; Burns, Karen E.A.; Vandvik, Per Olav; Coto-Yglesias, Fernando; Chrispim, Pedro Paulo M.; Ramsay, Tim (2010-03-24)CONTEXT: Theory and simulation suggest that randomized controlled trials (RCTs) stopped early for benefit (truncated RCTs) systematically overestimate treatment effects for the outcome that precipitated early stopping. ...
Montori, Victor M.; Devereaux, P.J.; Adhikari, Neill K.J.; Burns, Karen E.A.; Eggert, Christoph H.; Briel, Matthias; Lacchetti, Christina; Leung, Teresa W.; Darling, Elizabeth; Bryant, Dianne M.; Bucher, Heiner C.; Schunemann, Holger J.; Meade, Maureen O.; Cook, Deborah J.; Erwin, Patricia J.; Sood, Amit; Sood, Richa; Lo, Benjamin; Thompson, Carly A.; Zhou, Qi; Mills, Edward; Guyatt, Gordon H. (2005-11-02)CONTEXT: Randomized clinical trials (RCTs) that stop earlier than planned because of apparent benefit often receive great attention and affect clinical practice. Their prevalence, the magnitude and plausibility of their ...